| Product Code: ETC417485 | Publication Date: Oct 2022 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United Kingdom import trend for corticosteroids experienced a notable decline, with a growth rate of -37.62% compared to the previous year. The compound annual growth rate (CAGR) for the period of 2020-2024 stood at -37.97%. This substantial decrease could be attributed to shifts in demand, changes in trade policies, or market instability during the period.
In the UK, the corticosteroids market is primarily driven by their extensive use in treating inflammatory conditions, allergies, and autoimmune disorders. Pharmaceutical advancements, coupled with rising incidences of chronic diseases, contribute to market growth. Regulatory approvals, patent expirations, and healthcare expenditure trends significantly influence market dynamics.
In the UK, the corticosteroids market is influenced by rising incidences of chronic diseases such as asthma, arthritis, and allergies, which necessitate effective anti-inflammatory treatments. Corticosteroids are pivotal in managing these conditions, driving demand among healthcare providers and patients alike. The market also benefits from ongoing research and development efforts aimed at enhancing drug efficacy and reducing side effects associated with prolonged corticosteroid use. Moreover, aging populations and increasing healthcare expenditures contribute to sustained market growth as corticosteroids remain integral to therapeutic regimens across various medical specialties.
The UK corticosteroids market faces challenges shaped by regulatory reforms, pricing pressures, and clinical efficacy expectations. Regulatory changes in drug approvals and pricing policies impact market access and profitability for manufacturers. Additionally, the emergence of generic alternatives and biosimilars intensifies competition, driving down prices and squeezing profit margins. Moreover, the demand for novel formulations and therapeutic innovations necessitates substantial R&D investments, posing financial constraints on market players. Adapting to these challenges requires strategic partnerships, portfolio diversification, and compliance with stringent regulatory standards to sustain market leadership and meet patient needs effectively.
The UK corticosteroids market is impacted by pharmaceutical regulations and healthcare policies. Government policies govern drug approvals, pricing regulations, and reimbursement schemes under the National Health Service (NHS). Regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA) oversee compliance with safety standards and clinical efficacy requirements.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Corticosteroids Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Corticosteroids Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Corticosteroids Market - Industry Life Cycle |
3.4 United Kingdom (UK) Corticosteroids Market - Porter's Five Forces |
3.5 United Kingdom (UK) Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United Kingdom (UK) Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory disorders in the UK |
4.2.2 Growing awareness about the benefits of corticosteroids in managing various medical conditions |
4.2.3 Technological advancements leading to the development of new corticosteroid products |
4.2.4 Rising healthcare expenditure and government initiatives to improve access to healthcare services |
4.2.5 Aging population in the UK leading to a higher demand for corticosteroids |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines governing the use of corticosteroids |
4.3.2 Side effects associated with long-term use of corticosteroids |
4.3.3 Competition from alternative treatment options such as non-steroidal anti-inflammatory drugs (NSAIDs) |
4.3.4 Limited reimbursement policies for corticosteroid treatments |
4.3.5 Fluctuating prices of raw materials impacting the cost of corticosteroid production |
5 United Kingdom (UK) Corticosteroids Market Trends |
6 United Kingdom (UK) Corticosteroids Market, By Types |
6.1 United Kingdom (UK) Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.1.4 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2021-2031F |
6.1.5 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.6 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.1.7 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
6.2 United Kingdom (UK) Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.4 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Research Institutes, 2021-2031F |
6.2.5 United Kingdom (UK) Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
7 United Kingdom (UK) Corticosteroids Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Corticosteroids Market Export to Major Countries |
7.2 United Kingdom (UK) Corticosteroids Market Imports from Major Countries |
8 United Kingdom (UK) Corticosteroids Market Key Performance Indicators |
8.1 Number of new corticosteroid product launches in the UK market |
8.2 Patient adherence rates to corticosteroid treatment regimens |
8.3 Number of clinical trials evaluating the efficacy and safety of corticosteroids in the UK |
8.4 Prescription rates of corticosteroids by healthcare providers in different regions of the UK |
8.5 Patient satisfaction and outcomes following corticosteroid treatment |
9 United Kingdom (UK) Corticosteroids Market - Opportunity Assessment |
9.1 United Kingdom (UK) Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United Kingdom (UK) Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Corticosteroids Market - Competitive Landscape |
10.1 United Kingdom (UK) Corticosteroids Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here